PHS
VYGR icon

PFM Health Sciences’s Voyager Therapeutics VYGR Stock Holding History

PFM Health Sciences’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,231,954
Closed -$21.2M – 80
2019
Q3 		$21.2M Sell
1,231,954
-885,434
-42% -$18.6M 0.63% 49
2019
Q2 		$57.6M Buy
2,117,388
+166,327
+9% +$3.81M 1.09% 28
2019
Q1 		$37.3M Buy
+1,951,061
New +$25.4M 0.83% 41
2017
Q4 		– Sell
-397,923
Closed -$8.19M – 102
2017
Q3 		$8.19M Sell
397,923
-455,202
-53% -$5.14M 0.16% 84
2017
Q2 		$7.64M Sell
853,125
-642,676
-43% -$6.47M 0.21% 81
2017
Q1 		$19.8M Buy
1,495,801
+111,650
+8% +$1.35M 0.5% 67
2016
Q4 		$17.6M Buy
1,384,151
+26,178
+2% +$336K 0.5% 61
2016
Q3 		$16.3M Buy
1,357,973
+22,302
+2% +$302K 0.48% 62
2016
Q2 		$14.7M Buy
1,335,671
+442,130
+49% +$5.41M 0.44% 63
2016
Q1 		$7.34M Sell
893,541
-3,093
-0.3% -$35.1K 0.23% 71
2015
Q4 		$17.1M Buy
+896,634
New +$20.7M 0.52% 48

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

PFM Health Sciences's VYGR Position: Q4 2019 in Review

PFM Health Sciences sold out of Voyager Therapeutics (VYGR) in Q4 2019, closing a stake of 1,231,954 shares — an estimated $21.2M sold.

PFM Health Sciences first reported a position in VYGR in Q4 2015 and held it in 11 quarters. The position peaked at $57.6M in Q2 2019. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

  • PFM Health Sciences reported no remaining Voyager Therapeutics position as of Q4 2019 after selling out during the quarter.
  • PFM Health Sciences sold 1,231,954 Voyager Therapeutics shares in Q4 2019, an estimated $21.2M.
  • PFM Health Sciences first reported a position in Voyager Therapeutics in Q4 2015 and held it in 11 quarters.
  • PFM Health Sciences's Voyager Therapeutics position peaked at $57.6M in Q2 2019.
  • 138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.